Delves into all aspects of R&D and manufacturing of all oral solid dose (OSD) forms. Tracks industry trends. Relays latest applied research relevant to OSDs. Provides “how to” information for the latest techniques in formulation/excipients, tablet manufacturing, capsule filling and other aspects of the process—including logistics like supply-chain management.
A continuing debate for established, emerging, and virtual biopharmaceutical companies is whether or not to outsource production to a CMO. At its core, the issue is about brand protection. While ...
read more
API molecules intended for oral administration are often categorized using the Biopharmaceutical Classification System (BCS), which indicates the primary factors affecting API bioavailability and, ...
read more
In recent years, parenterally delivered biologics have increasingly penetrated the pharmaceutical market due to their growing use in regenerative and personalized medicine as well as the development ...
read more
Developing new drug products is very expensive, especially when formulating new chemical entities (NCEs). Many pharmaceutical companies are turning to FDCs as a way to reduce those development costs. ...
read more
Better supply chain management has enabled some pharmaceutical companies to cut costs by 25 to 50 percent. Outsourcing packaging to a contract packaging organization (CPO), for example, transfers ...
read more
Large pharmaceutical companies currently source less than 10 percent of the excipients they use from India and prefer to engage with suppliers located in developed pharmaceutical markets. However, the...
read more
A continuing debate for established, emerging, and about brand protection. While outsourcing can minimize your capital and labor costs, it can be challenging to evaluate CMOs and determine which one ...
read more
API molecules intended for oral administration are often API bioavailability and, subsequently, directs the formulation strategy required to support the drug product’s development. The system uses the...
read more
In recent years, parenterally delivered biologics have increasingly penetrated the pharmaceutical market due to their growing use in regenerative and personalized medicine as well as the development ...
read more
Developing new drug products is very expensive, especially when formulating new chemical entities (NCEs). Many pharmaceutical companies are turning to FDCs as a way to reduce those development costs. ...
read more
Large pharmaceutical companies currently source less than 10 percent of the excipients they use from India and prefer to engage with suppliers located in developed pharmaceutical markets. However, the...
read more
Hard capsules, also known as two-piece capsules, offer an extremely versatile drug delivery method. Most are dryfilled with powders, granules, pellets, tablets, or mini-tablets. But hard capsules also...
read more
Abuse of opioid painkillers in the US is a major problem contributing to an escalating drug overdose epidemic. According to the US Department of Health & Human Services, 12.5 million people misused ...
read more
Wet high-shear mixer granulation is a particle size enlargement process in which fine powder is combined with a liquid binder. As the binder is sprayed into the process bowl, the granulator’s impeller...
read more
PureNSM (also known as Nutritional Supplement Manufacturers), Chula Vista, CA, is a contract manufacturer of nutritional supplements. It produces more than 900 million capsules per year, usually ...
read more